Hohl Benjamin
CHIEF FINANCIAL OFFICER · 18 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-17 | ELVN | Enliven Therapeutics, Inc. | Sale | 3,401 | $43.86 | $149,179.42 | filing |
| 2026-06-17 | ELVN | Enliven Therapeutics, Inc. | Sale | 1,379 | $42.79 | $59,000.52 | filing |
| 2026-06-17 | ELVN | Enliven Therapeutics, Inc. | Sale | 1,238 | $44.75 | $55,397.41 | filing |
| 2026-06-17 | ELVN | Enliven Therapeutics, Inc. | Option exercise | 6,018 | $2.48 | $14,924.64 | filing |
| 2026-02-12 | ELVN | Enliven Therapeutics, Inc. | Award | 25,000 | $0.00 | $0.00 | filing |
| 2025-12-22 | ELVN | Enliven Therapeutics, Inc. | Option exercise | 13,000 | $2.48 | $32,240.00 | filing |
| 2025-09-29 | ELVN | Enliven Therapeutics, Inc. | Sale | 3,250 | $20.40 | $66,291.23 | filing |
| 2025-09-29 | ELVN | Enliven Therapeutics, Inc. | Option exercise | 3,250 | $2.48 | $8,060.00 | filing |
| 2025-08-27 | ELVN | Enliven Therapeutics, Inc. | Sale | 3,250 | $20.63 | $67,038.73 | filing |
| 2025-08-27 | ELVN | Enliven Therapeutics, Inc. | Option exercise | 3,250 | $2.48 | $8,060.00 | filing |
| 2025-07-28 | ELVN | Enliven Therapeutics, Inc. | Sale | 3,185 | $20.45 | $65,119.24 | filing |
| 2025-07-28 | ELVN | Enliven Therapeutics, Inc. | Option exercise | 3,250 | $2.48 | $8,060.00 | filing |
| 2025-07-28 | ELVN | Enliven Therapeutics, Inc. | Sale | 65 | $21.30 | $1,384.52 | filing |
| 2025-07-10 | ELVN | Enliven Therapeutics, Inc. | Sale | 1,000 | $22.66 | $22,655.00 | filing |
| 2025-07-10 | ELVN | Enliven Therapeutics, Inc. | Option exercise | 1,000 | $2.48 | $2,480.00 | filing |
| 2025-06-27 | ELVN | Enliven Therapeutics, Inc. | Sale | 3,052 | $20.86 | $63,667.47 | filing |
| 2025-06-27 | ELVN | Enliven Therapeutics, Inc. | Option exercise | 3,250 | $2.48 | $8,060.00 | filing |
| 2025-06-27 | ELVN | Enliven Therapeutics, Inc. | Sale | 198 | $21.66 | $4,288.34 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.